Nature Communications (Jul 2017)

A point-of-care microfluidic biochip for quantification of CD64 expression from whole blood for sepsis stratification

  • U. Hassan,
  • T. Ghonge,
  • B. Reddy Jr.,
  • M. Patel,
  • M. Rappleye,
  • I. Taneja,
  • A. Tanna,
  • R. Healey,
  • N. Manusry,
  • Z. Price,
  • T. Jensen,
  • J. Berger,
  • A. Hasnain,
  • E. Flaugher,
  • S. Liu,
  • B. Davis,
  • J. Kumar,
  • K. White,
  • R. Bashir

DOI
https://doi.org/10.1038/ncomms15949
Journal volume & issue
Vol. 8, no. 1
pp. 1 – 12

Abstract

Read online

Sepsis is a potentially life–threatening complication of infection and diagnosis depends on rapid assessment of leukocyte count and CD64 expression. Here the authors present a microfluidic chip that can quantify these parameters from minimal amounts of whole blood with no manual processing.